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ABSTRACT 
Objective: Given the importance of the association between diabetes and periodontal disease, the main objective of the present study was to 
compare the microbial diversity responsible for gingivitis in patients with and without type 2 diabetes. 
Methods: Samples were collected from the oral cavity of 134 patients with gingivitis and categorised into 3 groups (68 non-diabetic patients and 66 
diabetic patients; 33 with controlled diabetes and 33 with poorly controlled diabetes). Sample culture was carried out on selective culture media. 
The identification of isolated strains involved a series of biochemical tests including miniature galleries (API 20E and 20 Strep), the traditional 
biochemical gallery (tubes) and automated bacterial identification (BD Phoenix™). 
Results: Identification by biochemical methods made it possible to differentiate 14 bacterial species and one yeast. There was greater bacterial 
diversity in diabetic patients as compared to non-diabetic patients. Periodontal pathogens were isolated from both diabetic and non-diabetic 
populations; however, certain microbes such as Streptococcus acidominimus, Enterobacter cloacae, Klebsiella oxytoca, and Pseudomonas aeruginosa 
were present only in diabetics, with a much higher percentage in those with poorly controlled diabetes. 
Conclusion: Poorly controlled diabetes causes metabolic dysregulation that can increase the severity of periodontal disease. 
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Oral diseases in diabetic patients have accelerated progression when the 
control of blood glucose is inadequate [1]. Advanced hyperglycemia may 
cause impairment of salivary gland function, the proliferation of 
pathogenic microorganisms, and progression of gum disease [2-4]. 
The prevalence of periodontal disease in diabetics is highly variable. 
It has been shown that 100% of diabetic patients had periodontal 
disease compared with 50% of control individuals [4, 5]. 
It is well documented that diabetics are more likely to develop 
periodontal infections than individuals without diabetes [6, 7]; with 
a reported prevalence of 9.8% in type 1 diabetics compared with 
1.6% in non-diabetic patients. In patients with type 2 diabetes, 
which is the most common form of diabetes (95% of the diabetic 
population [8]), the risk of periodontal disease is three times higher 
than in the general population [9]. 
It is not well known that periodontal disease is considered the sixth 
greatest complication of diabetes, especially when the disease is not 
appropriately controlled [10, 11], and determines changes in the 
bacterial population and production of inflammatory mediators, 
which reduces the effectiveness of the host response [12]. Controlled 
diabetes does not pose a major risk of periodontitis, and the results 
of initial and surgical periodontal therapy are better in these 
patients. In addition, periodontal therapy can reduce insulin demand 
in diabetics [13]. 
As a result, periodontal diseases and diabetes have a bi-directional 
link [14]. The treatment of diabetes therefore also involves the 
treatment of periodontal disease and the maintenance of rigorous 
oral hygiene [15]. Reciprocally, healthy periodontal status and good 
plaque control will, in turn, improve glycemic control, resulting in a 
significant reduction in glycated hemoglobin (HbA1c) [16]. 
Given the importance of the association between diabetes and 
periodontal disease, the main goal of the present study was to 
investigate how diabetes affects host-bacterial interactions by 
focusing on the microbial diversity responsible for gingivitis in 
patients with and without type 2 diabetes. 
MATERIALS AND METHODS 
The present study was carried out at the Dental Office of the Centre 
for Chronic Diseases, Sale, Morocco. Before taking the samples, all 
participants signed their consent.  
Target population 
-Group I: 68 non-diabetic subjects. 
-Group II: 33 diabetic subjects with controlled diabetes. 
-Group III: 33 diabetic subjects with poorly controlled diabetes. 
Sample collection 
Swab specimens were taken from the oral cavity of diabetic and non-
diabetic patients with gingivitis and streaked onto culture media. 
Subjects who used antiseptic mouthwashes during the week prior to 
collection, as well as those who took antibiotics in the previous 
month, were excluded from the study. Individuals of both genders 
were included, who did not suffer from systemic diseases other than 
type 2 diabetes, were non-smokers, and did not carry dentures or 
orthodontic appliances. Pregnant or breastfeeding women were also 
excluded from the present study. 
Seeding and isolation 
Sample seeding was carried out on cystine lactose electrolyte 
deficient (CLED) or bromocresol purple (BCP) medium and 
incubated at 37°C for 24 h. Purification of bacterial colonies was 
performed by successive subcultures on the same medium or 
another selective medium. 
Pseudomonas aeruginosa strains were isolated on nutrient agar 
supplemented with cetrimide, Escherichia coli and Klebsiella strains 
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were isolated on methylene blue eosin (MBE) agar, and Streptococcus 
and Enterococcus strains were isolated on blood agar. All plates were 
incubated at 37 °C in a 10% CO2
The data were analyzed using SPSS (Statistical Package for Social 
Sciences) software version 21. The Kolmogorov-Smirnov test was 
used to study the distribution of the quantitative variable, age, which 
is expressed as the median and quartile. Comparison of the 
qualitative variables among the three populations (gender, hygiene 
parameters, and microbial flora) was carried out by the Pearson 
khi2 test or Fisher's lowest difference test (LSD). The Mann Whitney 
test was used to compare variables with non-Gaussian distribution 
(age of patients). A value of p<0.05 is considered statistically 
significant. 
 atmosphere for 24 h [17]. 
Identification of isolated pathogens 
Identification of strains was based on a series of preliminary tests 
(appearance of colonies, Gram stain), biochemical tests (catalase, 
oxidase, coagulase, and DNase), and identification by miniature galleries 
(API 20E and 20 Strep), the traditional biochemical gallery (tubes), and 
automated bacterial identification (BD Phoenix™) [18, 19]. 
Statistical analysis 
RESULTS  
Distribution of the studied population 
Statistical analysis allowed us to divide our samples according to the 
demographic and hygiene parameters presented in table 1. 
 
Table 1: Distribution of the diabetic and non-diabetic populations by demographic and hygiene parameters 
Variables Study population n=134 p 
Non-diabetic patients n = 68 Diabetic patients n = 66 
Age 55 (39.75-60) a 50 (33.50-59.25) 0.168 
Gender  b  0.491 
Female 44(31.4%) 48(68.6%)  
Male 24(40.0%) 18(60.0%)  
Calculus  b  0.650 
Absent 18(30.0%) 21(70.0%)  
Present 50(35.7%) 45(64.30%)  
Brushing  b  0.827 
No 26(36.1%) 23(63.9%)  
Yes 42(32.8%) 43(67.2%)  
aValues are expressed as the median and quartiles, b
 
Identification of isolated pathogens 
15 strains were isolated, and their identification revealed 14 bacteria 
including 8 genres; Streptococcus, Enterococcus, Staphylococcus, 
Enterobacter, Escherichia, Klebsiella, Pseudomonas, and Lactobacillus, 
as well as one yeast Candida albicans (table 2). 
values are expressed as numbers and percentages. p<0.05 is considered statistically significant. 
The median age of the population was 52 (36-60) with extremes of 21 and 66 y old. The distribution by gender revealed a female predominance of 
70% and a gender ratio of 0.42. The oral examination revealed the presence of calculus in 70% of the study population. 63% of the entire population 
brushed their teeth daily. 
Periodontal pathogens were present in both diabetic and non-
diabetic populations. There was greater bacterial diversity in 
diabetic patients compared with non-diabetic subjects, with certain 
pathogens such as Streptococcus acidominimus, Enterobacter cloacae, 
Klebsiella oxytoca, and Pseudomonas aeruginosa only being present 
in diabetics. 
 
Table 2: Distribution of pathogens isolated from the oral flora of diabetic and non-diabetic patients with gingivitis 
Strain Study population =134 p 
Non-diabetic patients n = 68 Diabetic patients n = 66 
Streptococcus constellatus  4(18.2%) 9(81.8%) 0.324 
Streptococcus acidominimus  0(0%) 16(100%) 0.002 
Streptococcus oralis 14(26.9%) 19(73.1%) 0.373 
Enterococcus faecalis  10(26.3%) 14(73.7%) 0.432 
Streptococcus spp  14(58.3%) 5(41.7%) 0.1 
Streptococcus sanguinis  10(50%) 5(50%) 0.301 
Streptococcus mitis 12(50%) 6(50%) 0.329 
 Streptococcus mutans  2(100%) 0(0%) 0.113 
Staphylococcus aureus  6(30%) 7(70%) 1.000 
Enterobacter cloacae  0(0%) 20(100%) 0.001 
Klebsiella oxytoca  0(0%) 14(100%) 0.002 
Escherichia coli  2(12.5%) 7(87.5%) 0.259 
Pseudomonas aeruginosa 0(0%) 7(100%) 0.002 
Lactobacillus acidophilus 6(30%) 7(70%) 1.000 
Candida albicans  8(28.6%) 10(71.4%) 0.767 
Values are expressed as numbers and percentages. p<0.05 is considered statistically significant. 
 
The distribution of the diabetic population according to glycemic 
balance revealed that 50% of the population presents with poorly 
controlled diabetes (fig. 1). 
It is noteworthy that the percentage of ten microbial species 
identified in diabetic patients with poorly controlled diabetes is 
much higher than that in the group with controlled diabetes 
(Streptococcus constellatus (48%), Streptococcus acidominimus 
(63%), Streptococcus oralis (43%), Enterococcus faecalis (53%), 
Staphylococcus aureus (60%), Enterobacter cloacae (80%), Klebsiella 
oxytoca (93%), Escherichia coli (63%), Pseudomonas aeruginosa 
(100%), and Candida albicans (58%). Moreover, these species are 
also present in very high numbers as compared with non-diabetic 
subjects.
Hsaine et al. 




Fig. 1: Distribution of microbial species according to glycemic equilibrium within the study population 
 
DISCUSSION 
Diabetes can cause many serious systemic complications, with the 
classics including retinopathy, nephropathy, neuropathy, 
macrovascular, cerebrovascular, cardiovascular, and peripheral 
disorders [20], in addition to major alterations in the healing 
process. Increasing scientific evidence has also linked diabetes with 
periodontal disease [21, 22]. The objective of the present study was 
to compare the microbial diversity responsible for gingivitis 
between diabetic and non-diabetic patients. 
Based on clinical and radiological parameters, diabetic patients have 
shown an aggressive tendency towards bone loss as compared with 
healthy controls, suggesting that diabetes influences periodontal tissue 
destruction [23]. This is in accordance with studies that have 
demonstrated that a subject with type 2 diabetes is 2.8-3.4 times more 
likely to develop periodontal disease than a healthy subject [23, 24]. 
Numerous epidemiological studies have shown that the incidence and 
prevalence of periodontitis, in addition to the severity of periodontal 
destruction, are higher in patients with type 1 and type 2 diabetes [25-
29]. Nelson et al., have shown that the prevalence of periodontal 
disease is approximately 60% higher in diabetic patients as compared 
with their non-diabetic counterparts [30]. 
In the present study, the bacteriological analysis showed a high 
concentration of microbial species considered as pathogenic 
(Streptococcus acidominimus, Enterobacter cloacae, Klebsiella 
oxytoca, and Pseudomonas aeruginosa) in diabetic subjects as 
compared with non-diabetic subjects, which is consistent with 
results reported by Sbordon et al., [31]. In patients with poorly 
controlled diabetes and periodontal problems, the percentage of the 
most virulent microbial species was higher than in subjects with 
controlled diabetes and non-diabetic subjects, which is in agreement 
with data reported by Seppaa and Ainamo [32]. Epidemiological 
studies have also shown that type 2 diabetes can be predictive of 
periodontal disease when the systemic conditions are poorly 
controlled [33, 34], in addition to responding poorer to surgical and 
non-surgical periodontal treatments [35, 36]. 
CONCLUSION 
The results of the present study suggest that poorly controlled 
diabetes causes metabolic dysregulation that can increase the 
severity of periodontal disease. Numerous studies have shown that 
diabetes is associated with an increased risk of periodontal disease, 
which can be considered the sixth true complication of diabetes. 
Similarly, an oral infection can influence blood glucose control, 
insulin resistance, and the occurrence of complications associated 
with diabetes. Although more powerful studies are needed to 
complete the demonstration of the link between periodontal disease 
and glycemic control, we can already recommend integrating 
rigorous oral examination and necessary periodontal care 
(preventive and curative) into the management of diabetic patients. 
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